Clinical trial
Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on…
NCT00484900 · Dafra Pharma, Industry · Completed
Key facts
| NCT number | NCT00484900 |
|---|---|
| Title | Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria |
| Official title | Open Randomized Multi-Centre Trial, Comparing Artesunate-Sulfamethoxypyrazine-Pyrimethamine FDC Over 3 Days, Artesunate-Sulfamethoxypyrazine-Pyrimethamine FDC Over 48 Hours and Artemether-Lumefantrine FDC Over 3 Days on P. Falciparum Malaria |
| Lead sponsor | Dafra Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum Malaria |
| Intervention type | Drug |
| Interventions | Co-Arinate FDC, Coartem |
| Enrollment | 1,390 |
| Start date | May 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Jun 11, 2007 |
| Last update posted | Mar 26, 2008 |
| Countries | Cameroon, Mali, Rwanda, Sudan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: